Raidium Introduces AI Imaging Platform for U.S. Cancer Centers
Jul 17, 2026
Healthcare
Invenio Imaging Completes Enrollment in AI Lung Cancer Biopsy Study
August 03, 2026
Invenio Imaging has completed enrollment in the ON-SITE study of NIO Lung Cancer Reveal, an AI image analysis module for assessing bronchoscopic lung biopsy specimens.
Invenio Imaging said in a press release that it has completed patient enrollment in the ON-SITE study, a U.S. pivotal study of NIO Lung Cancer Reveal. The AI image analysis module is being evaluated for rapid assessment of bronchoscopic lung biopsy specimens imaged with the NIO Imaging System.
The multicenter study enrolled 1,006 patients at seven medical centers, with participation from 32 physicians. It collected more than 3,250 fresh biopsy specimens across four bronchoscopic biopsy techniques.
The NIO Imaging System images fresh, unprocessed biopsy tissue without traditional freezing, sectioning, or staining. The specimen remains available for later pathology and molecular analysis. NIO Lung Cancer Reveal has received FDA Breakthrough Device Designation for its intended use to assist physicians in evaluating bronchoscopic lung forceps biopsies, and Invenio will analyze the ON-SITE validation data for a regulatory submission.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Life Sciences
08/03
Parlance Adds Instant Voice Agent Settings and AI Call Summaries
08/03
Genprex and Roche Diagnostics to Validate TROP2 Biomarker Assays for Lung Cancer Trials
08/03
Signant Health Launches Forecasting & Planning Assist for Clinical Supplies
08/03
AI Oxygen System Improves Target Range Time in Hospital Trial
07/31
Ping An Insurance Adds AI Coach to Health Longevity System
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation
The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.
Read more